Atrophy of fast myofibers is a common feature in several myopathies but is poorly recapitulated in animal models. Mutations in the gene encoding leiomodin-3 (LMOD3) have been detected in individuals with nemaline myopathy (NM), a common congenital disorder associated with muscle weakness and the presence of rod-like structures (nemaline bodies) in both fast and slow skeletal muscle fibers. To shed light on LMOD3 function in NM, Tian Xu and collaborators generated a mouse mutant in which they disrupted the expression of the LMOD3 gene. These mutants show typical features of NM, including severe muscle weakness, postnatal growth retardation, and nemaline bodies and disorganized sarcomeric structures in the skeletal muscles. Notably, these animals exhibit atrophy specifically in fast myofibers. LMOD3 mutant mice are the first to experimentally model fast-myofiber atrophy, a unique clinical feature of several human myopathies. This mouse mutant can thus be used to further elucidate disease mechanisms and to identify potential targets for therapeutic purposes. Page 635
A new mouse model of fast-myofiber atrophy
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 June 2015
- Share Icon Share
-
Tools Icon
Tools
- Search Site
A new mouse model of fast-myofiber atrophy. Dis Model Mech 1 June 2015; 8 (6): e0603. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. Submission deadline: 4 July 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists